Icahn School of Medicine at Mount Sinai Beth Israel — New York, New York

Icahn School of Medicine at Mount Sinai Beth Israel is a clinical research site located in New York, New York, United States 10003.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Icahn School of Medicine at Mount Sinai Beth Israel has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Nonalcoholic Steatohepatitis, Parkinson's Disease, Primary Sclerosing Cholangitis.

Sponsors: Gilead Sciences, Bial R&D Investments, S.A., Exact Sciences Corporation.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Icahn School of Medicine at Mount Sinai Beth Israel?

Icahn School of Medicine at Mount Sinai Beth Israel has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Icahn School of Medicine at Mount Sinai Beth Israel conducted?

Icahn School of Medicine at Mount Sinai Beth Israel has 6 clinical trials on record, with 1 currently active. Their work covers Nonalcoholic Steatohepatitis, Parkinson's Disease, Primary Sclerosing Cholangitis.

Is Icahn School of Medicine at Mount Sinai Beth Israel accredited by Crixeo Health?

Icahn School of Medicine at Mount Sinai Beth Israel has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Icahn School of Medicine at Mount Sinai Beth Israel?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.